Overexpression of ALDH1A1 in many malignancies and cancer stem cells (CSCs) is strongly associated with poor prognosis, as well as tumor aggressiveness and drug resistance during conventional cancer chemotherapy 8. This evidence concerns the gene ALDH1A1 and neoplasm.